CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ABBV — AbbVie Inc.
CIK 884546
SAN FRANCISCO, CA
Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,249,736,836
+$429,457,447 QoQ
Shares Held
12,914,230
-0.4% QoQ
Ownership
0.731%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#19
of 4,167 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $34,394,076,697 across 15 Drug Manufacturers - General names. ABBV ranks #6 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,001,955 | $7,198,925,485 | |
| 2 | MRK |
Merck & Co., Inc.
|
54,365,289 | $6,985,939,635 | |
| 3 | AMGN |
Amgen Inc
|
15,034,038 | $5,444,125,839 | |
| 4 | JNJ |
Johnson & Johnson
|
19,126,165 | $4,857,472,124 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
67,595,177 | $3,894,834,098 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
12,914,230 | $3,249,736,836 | |
| 7 | PFE |
Pfizer Inc
|
52,548,228 | $1,265,361,329 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
8,155,281 | $1,030,338,200 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,249,736,836 | 12,914,230 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,820,279,389 | 12,967,398 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,751,057,654 | 25,169,844 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,010,339,861 | 25,958,106 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $4,971,521,527 | 26,783,329 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,293,299,030 | 25,263,932 | Shares | Other | 2025-09-15 | |
| 2024-12-31 | $4,875,400,833 | 27,436,133 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,707,290,670 | 23,836,797 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $4,283,639,446 | 24,974,577 | Shares | Other | 2024-08-12 | |
| 2024-03-31 | $4,136,822,879 | 22,717,314 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,789,322,565 | 24,451,975 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $3,391,049,413 | 22,749,560 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,071,446,815 | 22,797,052 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $3,432,296,866 | 21,536,656 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,457,869,588 | 9,020,912 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,197,093,879 | 8,919,558 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,350,589,845 | 8,818,163 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,443,587,604 | 8,904,988 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,181,901,454 | 8,728,962 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $922,934,641 | 8,555,990 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $959,841,597 | 8,521,321 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $911,390,205 | 8,421,643 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $872,819,898 | 8,145,776 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $711,993,971 | 8,128,713 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $830,470,551 | 8,458,653 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $536,092,116 | 7,036,253 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||